Revance Therapeutics (RVNC): AGN's Presentation Of Duration Data For Botox Is A Head-Scratcher - Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst, David Amsellem, reiterated his Overweight rating on shares of Revance Therapeutic (NASDAQ: RVNC) after attending Allergan’s Medical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
